![Peter S. Linsley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter S. Linsley
Keine laufenden Positionen mehr
Profil
Peter S.
Linsley formerly worked at Bristol Myers Squibb Co., as Immunology Director, Merck Research Laboratories Massachusetts LLC, as Executive Director-Cancer Biology, Sarepta Therapeutics, Inc., as Chief Scientific Officer & Senior Vice President from 2011 to 2012, Rosetta Inpharmatics LLC, as Vice President-Research & Development, and Regulus Therapeutics, Inc., as Chief Scientific Officer from 2008 to 2010.
Dr. Linsley received his undergraduate degree from Auburn University and doctorate degree from the University of California, Berkeley.
Ehemalige bekannte Positionen von Peter S. Linsley
| Unternehmen | Position | Ende |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2012 |
| REGULUS THERAPEUTICS INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2010 |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Corporate Officer/Principal | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Rosetta Inpharmatics LLC
 Rosetta Inpharmatics LLC BiotechnologyHealth Technology Develops and implements drug discovery technology | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Peter S. Linsley
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
84
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Rosetta Inpharmatics LLC
Rosetta Inpharmatics LLC BiotechnologyHealth Technology Develops and implements drug discovery technology | Health Technology |
Auburn University
 Auburn University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
Regulus Therapeutics, Inc.
 Regulus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in discovering and developing of drugs | Health Technology |
